BALCHEM ($BCPC) posted quarterly earnings results for Q4 2025 on Friday, February 20th. The company reported earnings of $1.31 per share, hitting estimates of $1.31. The company also reported revenue of $263,620,000, missing estimates of $264,777,036 by $-1,157,036.
You can see Quiver Quantitative's $BCPC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BALCHEM Insider Trading Activity
BALCHEM insiders have traded $BCPC stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $BCPC stock by insiders over the last 6 months:
- DAVID B FISCHER has made 0 purchases and 2 sales selling 8,000 shares for an estimated $1,231,748.
- GUNSTEREN JOB LEONARD VAN (SVP and GM, Specialty Products) has made 0 purchases and 2 sales selling 6,000 shares for an estimated $919,722.
- MARTIN LUTHER REID (SVP Chief Supply Chain Officer) sold 1,200 shares for an estimated $185,328
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BALCHEM Hedge Fund Activity
We have seen 190 institutional investors add shares of BALCHEM stock to their portfolio, and 224 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 229,035 shares (-75.0%) from their portfolio in Q4 2025, for an estimated $35,124,807
- ASSENAGON ASSET MANAGEMENT S.A. removed 180,572 shares (-64.9%) from their portfolio in Q4 2025, for an estimated $27,692,521
- GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC removed 145,979 shares (-41.0%) from their portfolio in Q4 2025, for an estimated $22,387,339
- CORIENT PRIVATE WEALTH LLC removed 136,731 shares (-55.3%) from their portfolio in Q4 2025, for an estimated $20,969,066
- HARVEY PARTNERS, LLC added 116,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $17,789,760
- TRIBUTARY CAPITAL MANAGEMENT, LLC removed 112,869 shares (-48.3%) from their portfolio in Q4 2025, for an estimated $17,309,589
- PITCAIRN CO removed 103,113 shares (-97.9%) from their portfolio in Q3 2025, for an estimated $15,473,136
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BALCHEM Analyst Ratings
Wall Street analysts have issued reports on $BCPC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 10/22/2025
To track analyst ratings and price targets for BALCHEM, check out Quiver Quantitative's $BCPC forecast page.
BALCHEM Price Targets
Multiple analysts have issued price targets for $BCPC recently. We have seen 2 analysts offer price targets for $BCPC in the last 6 months, with a median target of $176.0.
Here are some recent targets:
- Artem Chubarov from Rothschild & Co set a target price of $162.0 on 12/05/2025
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $190.0 on 10/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
